Clinical trial
A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer
NCT06800339
Study timeline
Study start (actual)2025-04-22Date precision: day
Registry last updated2026-05-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-Small Cell Lung Cancerunresolved
Interventions
NivolumabDRUG · verified · RxNorm: nivolumab
ChemotherapyDRUG
SBRTRADIATION
Surgical ResectionPROCEDURE
Sponsors & collaborators
University of Maryland, Baltimorelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06800339 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.